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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S77most strongly associated with activated macrophages in the capsule of
the tibiofemoral (TF) compartments (p¼0.0063) and the whole joint
synovium (p¼0.0017). sCD163 was also associated with severity of
radiographic OA, speciﬁcally joint space narrowing (p¼0.0554), but not
osteophyte severity. The use of the markers in combination improved
the prediction of activated macrophages in the capsule of the PF knee
compartment (p¼0.013) and joint space narrowing (p¼0.0099) inde-
pendent of osteophyte severity.
Conclusions: These ﬁndings suggest that cell-surface markers shed
from activated macrophages may be used as biomarkers to identify
a subtype of OA patients with an active inﬂammatory disease state. The
combined analysis of both CD14 and CD163 indicate synergism between
the markers for identifying the presence of activated macrophages in
the capsule of the PF knee and joint space narrowing. Furthermore,
these results contribute to a growing literature identifying macro-
phages and macrophage-activation pathways as potential targets for
new OA therapies.
Acknowledgements: Samples were obtained with support of a grant
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CHONDROCYTE HYPERTROPHY, MEASURED BY THE SECRETION OF
COLLAGEN TYPE X, IS A HALLMARK OF PATHOLOGICAL CHANGES
IN OSTEOARTHRITIS
Y. He y, N. Urik Brndt-Hansena y, J. Wang z, D. Su z, Q. Zheng z,
O. Simonsen x, K. Petersen k, M. Karsdal y, A.-C. Bay-Jensena y. yNordic
BioSci., Herlev, Denmark; zNordic BioSci. China, Beijing, China; xDept.
Orthopedic Surg, Aalborg Univ. Hosp., Aalborg, Denmark; kCtr. for
Sensory-Motor Interaction, Dept. of Hlth.Sci. and Technology, Aalborg
Univ., Aalborg, Denmark
Purpose: Collagen type X (Col X) is a short chain and network-forming
collagen, which is speciﬁcally synthesized by hypertrophic chondrocyte
in the growth plate during endochondral ossiﬁcation, the calciﬁed
cartilage in normal adult or the deep zone of osteoarthritic (OA) carti-
lage; thus Col Xmay play an important role in cartilage calciﬁcation. The
aim of the study was to measure serum levels Col X in OA patients as
well characterize the presence of the ColX in OA cartilage section.
Methods:Amonoclonal antibody (mAb)was raised against the 10aa at C-
terminus of NC1 domain of Col X. ThismAbwas characterized bywestern
blot using U2-OS osteosarcoma cell as positive control, and by immuno-
histochemistry on 5 human OA knee cartilages sections. A solid-phase
competitive ELISAwas developed applying the mAb and tested in a small
cohort including: 47 OA patients undergoing total knee replacement
surgery (mean age  SD: 6415), and 13 controls with knee problems
having arthroscopy (mean age SD: 3421), all women. Mann-Whitney
test was applied to compare the serum Col X levels in TKR and control
group. Pearson correlationwas done on log transformed data.
Results: The mAb, NB509-11G8, was speciﬁc for the immunogen; it did
not recognize truncated or nonsense peptides when tested in the ELISA.
The mAb detected the monomeric Col X (59KDa) and dimeric Col X
(120KDa) in the U2-OS cell lysate. Moreover, these bands were blocked
by the speciﬁc peptide. NB509-11G8 stained the extracellular matrix of
chondrocytes in the deep zone and calciﬁed cartilage of human OA
samples but not the middle or upper zone (ﬁg. A). The competitive
ELISA had a measuring range of 0.02-5 ng/ml, with intra- and inter-
assay CVs of 4.19% and 10.62%. The mean serum Col X level was
signiﬁcantly higher in the TKR than the control group (P¼0.017, ﬁg. B).
Serum Col X level did not correlate with age (R2¼0.055), but weakĂrelationwith BMI (R2¼0.17). The AUC for serum Col X for discriminating
TKR from controls was 0.72 (P¼0.017).
Conclusions: Secretion of Col X as a marker of cartilage hypertrophy
may serve as an early biomarker for OA burden of disease.
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CTX-II IS A MARKER OF CARTILAGE DEGRADATION BUT NOT OF
BONE TURNOVER
J. Catterall y, S. Dewitt Parr z, K. Fagerlund x, B. Caterson z. yDuke Univ.,
Durham, NC, USA; zCardiff Univ., Cardiff, United Kingdom; x Pharmatest
Services Ltd, Turku, Finland
Purpose: The CTx-II biomarker has been widely investigated and used
to determine the status of cartilage turnover in osteoarthritis and
rheumatoid arthritis. Recent publications have discussed the possibility
that CTx-II release may partially reﬂect bone turnover rather than being
a speciﬁc marker of cartilage turnover. As CTx-II has been used so
widely, it is clear that the speciﬁcity of CTx-II for cartilage needed to be
re-evaluated. To this end, we decided to investigate the speciﬁcity of
CTx-II for cartilage in comparison to the gold standard CTx-I bone
degradation marker. We investigated the speciﬁcity of the ELISAs for
their respective epitopes, release of CTx-I and CTx-II from bone and
cartilage explant cultures, and levels of CTx-II and CTx-I in a small acute
injury and osteoarthritis (OA) cohort.
Methods: ELISA speciﬁcity for CTx-I and CTx-II was determined by
depletion of the epitopes from urine and by afﬁnity puriﬁcation of the
epitopes. Release of CTx-I and CTx-II from bone and cartilage was
investigated by digesting both cartilage and bone with either cathepsin
K or matrix metalloproteinases, and release of CTx-I and CTx-II deter-
mined by ELISA. We also investigated the release of CTx-I and CTx-II in
explant culture from both bone by osteoclasts mediated bone degra-
dation and from pro-inﬂammatory cytokine-stimulated cartilage
explant cultures. Finally, we investigated the changes in CTx-I and CTx-
II in patient cohorts.
Results: In vitro, cathepsin K digestion of bone released CTx-I alone
while digestion of bone with activated MMPs was unable to release
either CTx-I or CTx-II from bone. Only digestion of cartilage by activated
MMPs released CTx-II, while digestion of cartilage by either MMPs or
cathepsin K was unable to release detectable CTx-I. Osteoclast digestion
of bone slices released only CTx-I and no detectable CTx-II, while the
reverse was true in chondrocyte-mediated cartilage degradation, with
high CTx-II release and no detectable CTx-I. In our OA patient cohorts
we observed an increase in CTx-II levels when compared to healthy
controls but no change in CTx-I, while acute injury patients demon-
strated a reduction in CTx-I levels after injury and no change in CTx-II.
Conclusions: Our data strongly suggest that CTx-I reﬂects bone
degradation and CTx-II reﬂects cartilage degradation, and that in acute
injury and in osteoarthritis, bone turnover and cartilage degradation/
repair processes differ. As CTx-II reﬂects cartilage degradation, it is
a valid biomarker of cartilage breakdown and not a biomarker of bone
turnover, although in some cases it may reﬂect the connected pathology
of bone and cartilage in joint diseases.
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CTX-II LEVELS ARE ASSOCIATED WITH PERIPHERAL BONE DENSITY,
SUGGESTING CTX-II EPITOPE RELEASE FROM BONE: DATA FROM
COHORT HIP AND COHORT KNEE (CHECK)
W.E. van Spil, K.L. Vincken, W.F. Lems, F.P. Lafeber. Univ. Med. Ctr.
Utrecht, Utrecht, The Netherlands
Purpose: Recent data have suggested that CTX-II (C-terminal telopep-
tide of collagen type II) may not only originate from articular cartilage
but also from bone changes. Therefore, the purpose of this study was to
look for cross-sectional associations between urinary CTX-II levels and
bone density distant from the subchondral bone area.
Methods: This study was performed in 366 subjects with early-stage
symptomatic knee and/or hip osteoarthritis from Cohort Hip and
Cohort Knee (CHECK). In urine (u-) and serum (s-) samples from these
subjects, uCTX-II, the cartilage markers sCOMP, sPIIANP, and sCS846
(cartilage oligomeric matrix protein, N-terminal propeptide of pro-
collagen type IIA, and chondroitin sulphate 846), and the bone markers
uNTX-I, uCTX-I, sPINP, and sOC (N and C-terminal telopeptides of
collagen type I, N-terminal propeptide of procollagen type I, and
osteocalcin) were assessed by enzyme-linked immunosorbent assay or
radioactive immunoassay. Bone density was determined at the tibia and
Figure 1. Mean concentrations ( SD) of COMP, hsCRP and Cholesterol.Ă
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S78femur, distant from the subchondral bone, on plain radiographs, with
Knee Images Digital Analysis, using an aluminium step wedge as
reference. To allow for adjustment for concurrent radiographic knee
and hip OA, the patellofemoral and tibiofemoral knee compartments
and hips were scored for joint space narrowing, osteophytes, and sub-
chondral sclerosis according to Altman and Burnett.
Results: The majority of subjects did show no or only minimal features
of radiographic knee and hip OA. After adjustment for demographic
variables (i.e. age, gender, and body mass index) and radiographic knee
and hip OA features, bone marker as well as uCTX-II levels, but not the
other cartilage markers, showed associations with peripheral bone
density (standardized betas¼0.103 to 0.183; P¼0.003 to 0.027).
Conclusions: This study warrants more cautious interpretation of CTX-
II as marker of (only) cartilage damage, since our data conﬁrm the
notion that CTX-II may also originate from peripheral bone changes.
130
GENETIC MARKERS FOR PREDICTING THE DEVELOPMENT AND
PROGRESSION OF KNEE OSTEOARTHRITIS
A. Mishra, Sr. y, D. Sanghi, II y, A.C. Sharma, Jr. y, D. Parmar, IV z,
R.N. Srivastava V y. yKing George's Med. Univ., Lucknow, India; z Indian
Inst. of Toxicology Res., Lucknow, India
Purpose: The present study was initiated to investigate the association
of SNPs in Estrogen receptor-a (ESR- a), Calmodulin-1 (CALM-1) and
Growth differentiation factor-5 (GDF-5) gene with osteoarthritis knee
(KOA).
Methods: In a case-control study, 300 cases with KOA and an equal
number of age, sex matched healthy controls were included. Cases were
diagnosed using the American college of rheumatology (ACR) guide-
lines of knee osteoarthritis (KOA). Blood was drawn for genomic DNA
isolation, polymerase chain reaction coupled restriction fragments
length polymorphism (PCR-RFLP) was carried out to identify the SNPs.
All statistical analysis was performed with the SPSS software package
(version 16.0 for windows; SPSS Chicago, IL).Results: The variant
genotype of ESR- a, CALM-1 and GDF-5 genes were found to be present
at relatively higher frequency in cases than in the controls. Risk
increased in cases that carried combination of variant genotypes of ESR
a (Btg-AA) and GDF-5(TT) or Calm-1(ApeKI-TG) and GDF-5(TT) or Calm-
1(ApeKI-TG) and ESR a (Btg-AA) resulting 4.00-6.00 fold elevated risk to
KOA. The haplotype T-G-C containing variant of all three polymorphism
of calm-1 gene was also over represented in the cases, increasing the
risk to 3.5 fold in cases. A signiﬁcant association of these variant
genotype was also found with clinical scores of KOA (VAS, WOMAC).
Conclusions: The results suggest that GDF-5, ESR-a and CALM-1 gene
polymorphism is associated with KOA and gene-gene interaction
inﬂuences the development of KOA. Likewise,association of these SNP
with clinical score has again demonstrated that these genetic markers
could be effectively used for predicting development and progression of
osteoarthritis. These can highlighting potential pathways for preven-
tion and therapeutic intervention of knee osteoarthritis.
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BIOMARKERS OF OSTEOARTHRITIS PROGRESSION
F.R. Saunders, K. Yoshida, R.J. Barr, H.M. Macdonald, D.M. Reid,
R.M. Aspden, J.S. Gregory. Univ. of Aberdeen, Aberdeen, United Kingdom
Purpose: to determine whether cartilage oligomeric matrix protein
(COMP), C-reactive protein hsCRP and cholesterol and its metabolites
could be used as biomarkers for osteoarthritis (OA) progression from
plasma samples in a cross sectional study.
Methods: COMP levels were determined from plasma samples (n¼57)
using a COMP ELISA (R&D systems). hsCRP, total cholesterol (TC), HDL
and LDL were determined by standard biochemical detection methods.
Kellgren-Lawrence grade (KLG) was assessed from radiographs by
a single clinician (KY). The knee with the worst KLG was used for
analysis. OA Severity groups were determined by grouping of KLG
(KLG¼0 both knees or KLG¼1 in one knee and KLG¼0 for the other
knee, no OA; KLG¼1 in both knees, mild OA; KLG¼2, moderate OA;
KLG¼3-4 severe OA). Plasma concentrations of all analytes were tested
using the one-way ANCOVA, weighted for KLG or OA severity and
adjusted for age and BMI in SPSS v20.0.
Results: Analysis of COMP levels in plasma showed elevated levels with
increasing KL grade but this was not statistically signiﬁcant (P¼0.159).
When grouped by severity, the increase in COMP levels was notstatistically signiﬁcant (P¼0.230). KLG¼2 had the highest levels of
COMP present (Fig. 1). hsCRP levels were not elevated above normal
limits (10mg/ml) and not related to increasing KLG or severity (P¼0.390
[KLG]; P¼0.286 [OA Severity]). Over 50% of the patient population had
TC levels higher than the recommended normal level of 4 mmol/L. TC
levels were statistically signiﬁcant between KLG (P¼0.046), but not
when related to OA severity (P¼0.053) although the P values are almost
identical. LDL levels were statistically signiﬁcantly increased in relation
to KLG and OA severity (P¼0.025 [KLG]; P¼0.030 [OA severity]). HDL
and the ratio between TC and HDL were not statistically signiﬁcant
when analysed by KLG or by OA severity (HDL P¼0.468 [KLG], P¼0.414
[OA severity]; TC/HDL ratio P¼0.899 [KLG], P¼0.894 [OA severity]).
Conclusions: Total cholesterol and LDL levels from plasma were asso-
ciated with increasing KLG and OA severity. There were elevated levels
of COMP detectable in plasma, however COMP levels were not signiﬁ-
cantly related to KLG or OA severity. There were no detectable levels of
inﬂammation present, as the levels of hsCRP detected were not above
normal levels (10 mg/ml) even with severe OA. hsCRP levels are
decreased by use of NSAIDs, however in this study this information was
not available and we therefore cannot determine whether NSAID use
had any effect on hsCRP levels reported in this population. Elevated
levels of TC and HDL peaked at KLG¼2 and then decreased. This may
indicate that patients with KLG of 3 or 4 are being treated for hyper-
cholesterolaemia, although therewas nomedication history available to
support this. This study indicated that TC and LDL may be surrogate
markers for OA. Currently other markers are being investigated.132
SHORT-TERM SAMPLING STABILITY OF SYNOVIAL FLUID
MEASUREMENTS IN KNEE OSTEOARTHRITIS
C. Jayadev, R. Rout, S. Snelling, P. Hulley, A. Price. Univ. of Oxford, Oxford,
United Kingdom
Purpose: Short-term ﬂuctuations in biomarker measurements unre-
lated to disease progression or treatment would invalidate the utility of
biomarkers for patient assessment. Burden of disease biomarkers in
end-stage knee OA should reﬂect the biological failure associated with
the extent of clinical and structural (radiographic) severity. They should
deﬁne a terminal proﬁle and benchmark that measurements from
earlier stages of disease progress towards. Consequently, one would
expect the synovial ﬂuid (SF) proﬁle of end-stage knee OA to be stable
over short periods of time during which there is no further structural or
clinical deterioration. This has never been formally tested and there are
very few studies with longitudinal SF analyses in knee OA patients. The
study aimed to determine whether SF measurements from patients
with end-stage knee OA remain stable over short periods of time.
Methods: SF was collected from 10 patients with end-stage knee OA
(N¼10) in the clinic room at their pre-operative assessment (POAC). A
second SF sample was collected for each patient at the time of primary
arthroplasty. Each participant completed the Oxford Knee Score (OKS)
and a Visual Analogue Pain score (VASpain) prior to sample collection at
each time point. To assess whether this small sample size was repre-
sentative of patients undergoing primary knee replacement for end-
stage knee OA, a further 15 patients (Reference group) were asked at
random to complete an OKS questionnaire at POAC and on the morning
